HPV vaccine strategies: the cost of HPV and the choice of vaccine

Sex Transm Infect. 2009 Sep;85(5):315-6. doi: 10.1136/sti.2008.034793.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Condylomata Acuminata / economics
  • Condylomata Acuminata / prevention & control
  • Cost-Benefit Analysis
  • Female
  • Health Policy
  • Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  • Humans
  • Papillomavirus Infections / prevention & control*
  • Papillomavirus Vaccines / economics*
  • United Kingdom
  • Uterine Cervical Neoplasms / prevention & control

Substances

  • Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  • Papillomavirus Vaccines
  • human papillomavirus vaccine, L1 type 16, 18